Similar results were reported by Ghelli Luserna Di Rorà et al., demonstrating that doxorubicin activates the ATR/CHK1 pathway and induces G2/M cell cycle arrest in ALL cell lines [36]. This evidence concerns the gene ATR and acute lymphoblastic leukemia.